APOBEC proteins and intrinsic resistance to HIV-1 infection

被引:210
|
作者
Malim, Michael H. [1 ]
机构
[1] Kings Coll London, Guys Hosp, Sch Med, Dept Infect Dis, London SE1 9RT, England
基金
英国医学研究理事会;
关键词
HIV-1; APOBEC3G; Vif; hypermutation; reverse transcription; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD MONONUCLEAR-CELLS; RNA-EDITING ENZYME; POLYPEPTIDE-LIKE; 3G; TO-A MUTATION; CYTIDINE DEAMINASE; TYPE-1; VIF; REVERSE TRANSCRIPTION; ANTIRETROVIRAL FACTOR; ANTIVIRAL ACTIVITY;
D O I
10.1098/rstb.2008.0185
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Members of the APOBEC family of cellular polynucleotide cytidine deaminases, most notably APOBEC3G and APOBEC3F, are potent inhibitors of HIV-1 infection. Wild type HIV-1 infections are largely spared from APOBEC3G/F function through the action of the essential viral protein, Vif. In the absence of Vif, APOBEC3G/F are encapsidated by budding virus particles leading to excessive cytidine (C) to uridine (U) editing of negative sense reverse transcripts in newly infected cells. This registers as guanosine (G) to adenosine (A) hypermutations in plus-stranded cDNA. In addition to this profoundly debilitating effect on genetic integrity, APOBEC3G/F also appear to inhibit viral DNA synthesis by impeding the translocation of reverse transcriptase along template RNA. Because the functions of Vif and APOBEC3G/F proteins oppose each other, it is likely that fluctuations in the Vif-APOBEC balance may influence the natural history of HIV-1 infection, as well as viral sequence diversification and evolution. Given Vif's critical role in suppressing APOBEC3G/F function, it can be argued that pharmacologic strategies aimed at restoring the activity of these intrinsic anti-viral factors in the context of infected cells in vivo have clear therapeutic merit, and therefore deserve aggressive pursuit.
引用
收藏
页码:675 / 687
页数:13
相关论文
共 50 条
  • [31] APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells
    Berger, Gregory
    Durand, Stephanie
    Fargier, Guillaume
    Xuan-Nhi Nguyen
    Cordeil, Stepanie
    Bouaziz, Serge
    Muriaux, Delphine
    Darlix, Jean-Luc
    Cimarelli, Andrea
    PLOS PATHOGENS, 2011, 7 (09)
  • [32] Natural Resistance to HIV Infection: the Vif-APOBEC Interaction
    Michael H Malim
    Retrovirology, 2
  • [33] Natural resistance to HIV infection: The Vif-APOBEC interaction
    Malim, Michael H.
    COMPTES RENDUS BIOLOGIES, 2006, 329 (11) : 871 - 875
  • [34] Proteins identified that may be essential for HIV-1 infection and survival
    Wilson, Hannah
    FUTURE VIROLOGY, 2013, 8 (04) : 328 - 328
  • [35] APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso
    Compaore, Tegwinde Rebeca
    Soubeiga, Serge Theophile
    Ouattara, Abdoul Karim
    Obiri-Yeboah, Dorcas
    Tchelougou, Damehan
    Maiga, Mamoudou
    Assih, Maleki
    Bisseye, Cyrille
    Bakouan, Didier
    Compaore, Issaka Pierre
    Dembele, Augustine
    Martinson, Jeremy
    Simpore, Jacques
    PLOS ONE, 2016, 11 (01):
  • [36] ELEVATION OF SALIVARY ANTIMICROBIAL PROTEINS FOLLOWING HIV-1 INFECTION
    ATKINSON, JC
    YEH, CK
    OPPENHEIM, FG
    BERMUDEZ, D
    BAUM, BJ
    FOX, PC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 (01): : 41 - 48
  • [37] HIV infection and the risk of cancer: tumorigenicity of HIV-1 auxiliary proteins Comment
    Mowla, Shaheen
    Ahmed, Riyaadh
    FUTURE VIROLOGY, 2022, 17 (10) : 707 - 710
  • [38] Quantifying the antiviral effect of APOBEC3 on HIV-1 infection in humanized mouse model
    Kurusu, Tatsuya
    Kim, Kwang Su
    Koizumi, Yoshiki
    Nakaoka, Shinji
    Ejima, Keisuke
    Misawa, Naoko
    Koyanagi, Yoshio
    Sato, Kei
    Iwami, Shingo
    JOURNAL OF THEORETICAL BIOLOGY, 2020, 498
  • [39] HIV-1 transmission and acute HIV-1 infection
    Hansasuta, P
    Rowland-Jones, SL
    BRITISH MEDICAL BULLETIN, 2001, 58 : 109 - 127
  • [40] PREVALENCE AND PERSISTENCE OF ANTIBODY-TITERS TO RECOMBINANT HIV-1 CORE AND MATRIX PROTEINS IN HIV-1 INFECTION
    JANVIER, B
    MALLET, F
    CHEYNET, V
    DALBON, P
    VERNET, G
    BESNIER, JM
    CHOUTET, P
    GOUDEAU, A
    MANDRAND, B
    BARIN, F
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (08): : 898 - 903